Entellus Medical, Inc. Common Stock
ENTL
ENTL was delisted on the 27th of February, 2018.
55 hedge funds and large institutions have $228M invested in Entellus Medical, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 4 closing their positions.
182% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 11
4% more capital invested
Capital invested by funds: $220M → $228M (+$8.02M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less funds holding
Funds holding: 56 → 55 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MRM
Michael R. Murphy
|
+$2.5M |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$2.04M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.01M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.12M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$964K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.64M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.13M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$1.07M |
| 4 |
Citigroup
New York
|
-$70K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$63K |
ENTL Hedge Fund Activity: Q2 2016 in Review
55 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q2 2016, worth a combined $228M — up 3.6% from $220M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ENTL and 3 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 31 added.
The largest buyer was Michael R. Murphy, adding an estimated $2.5M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $3.64M sold.
- 55 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q2 2016, down from 56 in Q1 2016.
- Funds reported $228M of Entellus Medical, Inc. Common Stock stock for Q2 2016, up 3.6% quarter-over-quarter.
- 3 funds opened new Entellus Medical, Inc. Common Stock positions in Q2 2016 and 4 closed out, a net change of -1 holder.
- The largest Entellus Medical, Inc. Common Stock buyer in Q2 2016 was Michael R. Murphy, an estimated $2.5M added.
- The largest Entellus Medical, Inc. Common Stock seller in Q2 2016 was Adage Capital Partners, an estimated $3.64M sold.
Based on aggregated 13F filings for Q2 2016.